Compounds > guanfacine
Page last updated: 2024-10-28

guanfacine and Diabetes Mellitus, Type 2

guanfacine has been researched along with Diabetes Mellitus, Type 2 in 6 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
"30 patients with hypertension and diabetes mellitus type II were treated with guanfacine (Estulic--"Sandoz" Switzerland) 1 mg tablets in the course of 6 months."7.68[Guanfacine in the treatment of arterial hypertension in diabetics]. ( Belovezhdov, N; Daskalova, I; Monova, D, 1990)
"30 patients with hypertension and diabetes mellitus type II were treated with guanfacine (Estulic--"Sandoz" Switzerland) 1 mg tablets in the course of 6 months."3.68[Guanfacine in the treatment of arterial hypertension in diabetics]. ( Belovezhdov, N; Daskalova, I; Monova, D, 1990)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Monova, D1
Daskalova, I1
Belovezhdov, N1
Coves, MJ2
Gomis, R2
Casamitjana, R2
Lienas, V1
Vilaradell, E1
Dvorák, I1
Podrouzková, B1
Kocourková, J1
Kubesová, H1
Spác, J1
Nĕmcová, H1
Blaha, M1
Goday, A1
Rivera, F1
Vilardell, E1
Hauger-Klevene, JH2
Scornavacchi, JC2

Trials

2 trials available for guanfacine and Diabetes Mellitus, Type 2

ArticleYear
Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Cor et vasa, 1987, Volume: 29, Issue:4 Suppl 1

    Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabet

1987
Improvement of glucose tolerance in hypertensive diabetic patients treated with guanfacine one year.
    European journal of clinical pharmacology, 1985, Volume: 29, Issue:4

    Topics: Adult; Antihypertensive Agents; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2;

1985

Other Studies

4 other studies available for guanfacine and Diabetes Mellitus, Type 2

ArticleYear
[Guanfacine in the treatment of arterial hypertension in diabetics].
    Vutreshni bolesti, 1990, Volume: 29, Issue:6

    Topics: Adolescent; Adult; Aged; Blood Pressure; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Guanfac

1990
Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
    Journal of medicine, 1989, Volume: 20, Issue:3-4

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diab

1989
[Antihypertensive treatment with guanfacine in patients with type II diabetes mellitus].
    Medicina clinica, 1987, Feb-28, Volume: 88, Issue:8

    Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Female; Guanfacine; Guanidines; Humans; Hyperten

1987
Improved glucose tolerance after guanfacine treatment in hypertensive diabetic (type II) patients: one year follow up.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1985, Volume: 17, Issue:11

    Topics: Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Guanfacine; G

1985